Clinical trial

Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat

NCT02920190

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2020-09-01

PhasePHASE4

Study timeline

Study start (estimated)2020-09-01Date precision: day

Registry last updated2020-09-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Monoclonal Gammopathiesunresolved

Overweightunresolved

Obesityunresolved

Interventions

LiraglutideDRUG · verified · RxNorm: liraglutide

Sponsors & collaborators

University of Miamilead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02920190 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.